Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
$ 0
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Nhale, Inc. does not have significant operations. Previously, it was involved in the development and commercialization of technologies related to the medical marijuana market. The company was formerly known as Gankit Corporation and changed its name to Nhale, Inc. in May 2014. The company was incorporated in 2012 and is based in New York, New York. Nhale, Inc. operates as a subsidiary of Riverview Heights, LLC.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBI
Data is available to registered users only
Buy
Sell